283 related articles for article (PubMed ID: 32709663)
21. Successful treatment with bortezomib-containing regimen of primary plasma cell leukemia: a case report.
Obeidat MB; Al-Swailmeen AM; Arabeat AM; Abukamar AS
Pan Afr Med J; 2020; 36():15. PubMed ID: 32774592
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
[TBL] [Abstract][Full Text] [Related]
23. [Plasma cell leukemia].
Ravinet A; Bay JO; Tournilhac O
Bull Cancer; 2014 Nov; 101(11):1048-58. PubMed ID: 25418598
[TBL] [Abstract][Full Text] [Related]
24. Successful upfront cord blood transplantation for plasma cell leukemia in the first complete response after daratumumab therapy.
Ueno T; Sugio Y; Ohta T; Uehara Y; Ohno Y
Int J Hematol; 2021 Jun; 113(6):941-944. PubMed ID: 33483877
[TBL] [Abstract][Full Text] [Related]
25. Primary Plasma Cell Leukemia Revealed by a Mandibular Lesion: A Case Report.
Youssefi H; Ahnach M; Bendari M; Al Bouzidi A
Cureus; 2021 Dec; 13(12):e20148. PubMed ID: 35003980
[TBL] [Abstract][Full Text] [Related]
26. Plasma cell leukemia: concepts and management.
Liedtke M; Medeiros BC
Expert Rev Hematol; 2010 Oct; 3(5):543-9. PubMed ID: 21083471
[TBL] [Abstract][Full Text] [Related]
27. Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature.
Saccaro S; Fonseca R; Veillon DM; Cotelingam J; Nordberg ML; Bredeson C; Glass J; Munker R
Am J Hematol; 2005 Apr; 78(4):288-94. PubMed ID: 15795922
[TBL] [Abstract][Full Text] [Related]
28. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.
Tacchetti P; Pantani L; Patriarca F; Petrucci MT; Zamagni E; Dozza L; Galli M; Di Raimondo F; Crippa C; Boccadoro M; Barbato S; Tosi P; Narni F; Montefusco V; Testoni N; Spadano A; Terragna C; Pescosta N; Marzocchi G; Cellini C; Galieni P; Ronconi S; Gobbi M; Catalano L; Lazzaro A; De Sabbata G; Cangialosi C; Ciambelli F; Musto P; Elice F; Cavo M;
Lancet Haematol; 2020 Dec; 7(12):e861-e873. PubMed ID: 33242443
[TBL] [Abstract][Full Text] [Related]
29. [Primary plasmacytic lambda chain leukemia: report of a case].
Sztejnhaus AR; Santos RA; de Almeida TV
AMB Rev Assoc Med Bras; 1989; 35(3):120-2. PubMed ID: 2517460
[TBL] [Abstract][Full Text] [Related]
30. Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide.
Shibata S; Fukunaga A
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257362
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of AL amyloidosis in 2012; the benefit of new drugs (bortezomib, thalidomide, and lenalidomide). Summary of published clinical trials].
Adam Z; Sčudla V; Krejčí M; Cermáková Z; Pour L; Král Z
Vnitr Lek; 2013 Jan; 59(1):37-58. PubMed ID: 23428001
[TBL] [Abstract][Full Text] [Related]
32. Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone - a case report.
Wöhrer S; Ackermann J; Baldia C; Seidl S; Raderer M; Simonitsch I; Drach J
Hematol J; 2004; 5(4):361-3. PubMed ID: 15297854
[TBL] [Abstract][Full Text] [Related]
33. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
Wang H; Zhou H; Zhang Z; Geng C; Chen W
Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
[TBL] [Abstract][Full Text] [Related]
34. Systemic capillary leak syndrome preceding plasma cell leukaemia.
Ghosh K; Madkaikar M; Iyer Y; Pathare A; Jijina F; Mohanty D
Acta Haematol; 2001; 106(3):118-21. PubMed ID: 11713377
[TBL] [Abstract][Full Text] [Related]
35. The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma.
Hashimoto S; Kuroha T; Yano T; Sato N; Furukawa T
Intern Med; 2016; 55(20):3025-3028. PubMed ID: 27746443
[TBL] [Abstract][Full Text] [Related]
36. Successful bortezomib/dexamethasone induction therapy with lenalidomide in an elderly patient with primary plasma cell leukemia complicated by renal failure and pulmonary hypertension.
Tamura S; Koyama A; Shiotani C; Kurihara T; Nishikawa A; Okamoto Y; Fujimoto T
Intern Med; 2014; 53(11):1171-5. PubMed ID: 24881743
[TBL] [Abstract][Full Text] [Related]
37. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
[TBL] [Abstract][Full Text] [Related]
38. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
[TBL] [Abstract][Full Text] [Related]
39. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
40. [The clinical characteristics of patients with primary plasma cell leukemia and the efficacy of novel agents and hematopoietic stem cell transplantation].
Li WJ; Wang FR; Wen L; Chen Y; Chen H; Huang XJ; Lu J
Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):801-806. PubMed ID: 32987483
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
